13D Filing: OrbiMed Advisors and Xtant Medical Holdings Inc. (XTNT)

Page 2 of 14

Page 2 of 14 – SEC Filing

SCHEDULE 13D
CUSIP No.  98420P100
Page 2 of 14 Pages
1
NAME OF REPORTING PERSONS
OrbiMed Advisors LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS (See Instructions)
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
2,838,903 (1)
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
2,838,903 (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,838,903 (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.82% (2)
14
TYPE OF REPORTING PERSON (See Instructions)
IA
_______________________
(1)
Evidenced by (i) 2,751,184 shares of the Issuer’s Common Stock (“Shares”) and (ii) 87,719 Shares issuable upon the exercise of warrants to purchase Shares (the “Warrants”).
(2)
This percentage is calculated based upon 18,178,792 Shares of the Issuer outstanding on January 11, 2018, as set forth in the Issuer’s preliminary proxy statement dated January 11, 2018 relating to its special meeting of stockholders to be held on February 13, 2018, and includes an additional 87,719 Shares issuable upon the exercise of the Warrants, and 2,275,745 Shares issued on January 17, 2018 upon conversion of $1.627 million original principal amount, plus accrued interest, of the Issuer’s convertible notes.

Follow Xtant Medical Holdings Inc. (NYSE:XTNT)

Page 2 of 14